Clinical trials
Pemphigus Vulgaris clinical trials
Below are recruiting pemphigus vulgaris clinical trials, each written for real people, not researchers. We’re tracking 6 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07681388Recruiting
CAR-T cell therapy for hard-to-treat pemphigus
This study tests a new type of immune therapy called CAR-T cells, made from your own blood cells, to treat severe pemphigus vulgaris that hasn't responded to standard treatments like steroids and rituximab. The goal is to see if this treatment can control the disease and reduce the need for ongoing medications.
Wuhan, HubeiAges 18–70 - NCT07384221Recruiting
Gum health and disease severity in Pemphigus Vulgaris
This study looks at how Pemphigus Vulgaris (a rare blistering skin condition) affects gum health. Researchers will check your teeth and gums to see if the disease is linked to gum problems.
AnkaraAges 18 years+ - NCT04422912RecruitingPhase 1/Phase 2
Cell therapy trial for active pemphigus vulgaris
This Phase 1/2 trial tests the safety and dosing of genetically modified immune cells made from your own blood (autologous CAR T or related cells) for active pemphigus vulgaris. It may help control disease that is not adequately managed with standard medicines.
Redwood City, CaliforniaAges 18 years+ - NCT07641725Recruiting
Light Therapy and Steroid Rinse for Pemphigus Mouth Sores
This study tests whether a steroid mouthwash and/or light therapy (photobiomodulation) can help heal painful mouth sores caused by pemphigus vulgaris, an autoimmune disease that damages the inside of the mouth and skin.
DamascusAges 18–80 - NCT02753777Recruiting
Study for blistering autoimmune skin diseases
This study is for adults with certain autoimmune blistering skin conditions. Researchers want to better understand and test treatments that could improve symptoms and healing for people with these specific diseases.
Philadelphia, PennsylvaniaAges 18 years+ - NCT06581562RecruitingPhase 1
Testing rituximab plus AB-101 for autoimmune diseases
This trial tests a new treatment (AB-101) combined with rituximab for people with certain autoimmune diseases like rheumatoid arthritis, pemphigus vulgaris, vasculitis, or lupus. It is for those who have not had success with standard therapies.
Plantation, FloridaAges 18 years+
Hear when a new Pemphigus Vulgaris trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for pemphigus vulgaris?
- Yes. Clin2 currently lists 6 recruiting pemphigus vulgaris studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a pemphigus vulgaris trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a pemphigus vulgaris trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.